Theme: Enlightening acumen behind vision

World Ophthalmology 2016
Past Report of Ophthalmology 2015

World Ophthalmology 2016

ConferenceseriesLLC is inviting you to attend The World Ophthalmic Oncology Congress is going to be held during September 26-27, 2016 at Orlando, Florida ,USA. Ophthalmic Oncology 2016 which is one of the American Ophthalmology Conference will bring together world-class professors, scientists and ophthalmologist to discuss strategies for Ophthalmology, it aims to bridge the gap between large and medium pharmaceutical, biotech and diagnostic companies, leading universities and clinical research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe. World Ophthalmic Oncology Congress 2016 maximizes the opportunity to interact with and learn from your peers from across the country and across the globe it held with the discussions on: Ophthalmic Oncology, Intraocular Cancer, Retinoblastoma, Ocular Melanoma, Lymphoma of the Eye, Eyelid Carcinoma, Childhood eye Cancer, Eye Cancer Symptoms, eye Cancer Diagnosis, Eye cancer Treatment, Ophthalmologists and case reports.  

Retina and Retinal Disorders

The retina is a layer of tissue present in the interior of your eye. Retina  disorders are mainly due to lack of  light-delicate cells and other nerve cells which transform the impulse into visual information. Retina sends this visual data to the cerebrum through your optic nerve and process the information into an image and empowering you to see. Different age group generations, races and ethnicities are effected from Retinal degenerative disorders, for instance, Age-related macular degeneration and myopic macular degeneratio

Related Conferences:
International Conference and Expo on Cataract and Refractive Surgery  August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016  Madrid, Spain;9th World Ophthalmic Conference Oct 27-28, 2016 Istanbul, Turkey;10th International Conference on Clinical & Experimental Ophthalmology Nov 28-30, 2016 Dubai, UAE;6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; Future World Ophthalmology Congress of the International Council of Ophthalmology 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal.

Lacrimal System Disorders:

The lacrimal system is made up of the lacrimal gland that produces tears, and the “duct” that drains tears from the eye into the nose. The most common symptoms of lacrimal system problems are excess tearing (to the point that tears might run down the face) and mucous discharge. Having a plugged tear duct can lead to more serious issues than tears spilling over the eyelids and running down the face. Stagnant tears within the system can become infected and cause recurrent red eyes and infections. Excessive tearing can also produce secondary skin changes on the lower eyelids.

Related Conferences:
7th European Ophthalmology Conferences December 05-06, 2016  Madrid, Spain; 9th World Ophthalmic Conference Oct 27-28, 2016 Istanbul, Turkey;10th International Conference on Clinical & Experimental Ophthalmology Nov 28-30, 2016 Dubai, UAE;6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference and Expo on Cataract and Refractive Surgery August 04-05, 2016 Manchester, UK; Adaptive Optics and Wave front Control in Microscopy and Ophthalmology5–7 October 2015 Paris, France; European Association for Vision and Eye Research 2015 Nice 7–10 October 2015 Nice, France; Endocannabinoid Pharmacology Meeting – 2015 29–30 October 2015 Bern, Switzerland; Future World Ophthalmology Congress of the International Council of Ophthalmology 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States.

Cornea and External Eye Diseases:

The cornea is the transparent, clear layer at the front and center of the eye. In fact, the cornea is so clear that one may not even realize it is there. The cornea is located just in front of the iris, which is the colored part of the eye. The main purpose of the cornea is to help focus light as it enters the eye. If one wears contact lenses, the contact lens rests on the cornea.

Related Conferences:
9th World Ophthalmic Conference Oct 27-28, 2016 Istanbul, Turkey;10th International Conference on Clinical & Experimental Ophthalmology Nov 28-30, 2016 Dubai, UAE;6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference and Expo on Cataract and Refractive Surgery  August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016  Madrid, Spain;8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; Adaptive Optics and Wave front Control in Microscopy and Ophthalmology 5–7 October 2015 Paris, France; European Association for Vision and Eye Research 2015 Nice 7–10 October 2015 Nice, France.

Glaucoma and its Management:

Glaucoma is a multifactorial optic neuropathy that affects more than 50 million people and is the second leading cause of blindness worldwide. The role of intra ocular pressure (IOP) has been well documented as a major modifiable risk factor for glaucoma. Additionally, many glaucoma patients have a relatively low IOP, while some healthy individuals have a relatively high IOP. The disorders can be roughly divided into two main categories, open-angle glaucoma and closed-angle glaucoma. Impaired ocular blood flow regulation in open angle glaucoma as a risk of glaucoma has also been well established, especially over the past two decades. Pathophysiology of glaucoma indicates towards the increased in intraocular pressure which compresses and damages the optic nerve. Once the optic nerve is damaged, it fails to carry visual information to the brain and this result in loss of visionGlaucoma accounts for over 10 million visits to physicians each year. In terms of Social Security benefits, lost income tax revenues, and health care expenditures, the cost to the U.S. government is estimated to be over $1.5 billion annually.

Related Conferences:
6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference and Expo on Cataract and Refractive Surgery  August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016  Madrid, Spain;9th World Ophthalmic Conference Oct 27-28, 2016 Istanbul, Turkey;10th International Conference on Clinical & Experimental Ophthalmology Nov 28-30, 2016 Dubai, UAE; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; Adaptive Optics and Wave front Control in Microscopy and Ophthalmology 5–7 October 2015 Paris, France; European Association for Vision and Eye Research 2015 Nice 7–10 October 2015 Nice, France; Endocannabinoid Pharmacology Meeting – 2015 29–30 October 2015 Bern, Switzerland; Future World Ophthalmology Congress of the International Council of Ophthalmology 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States.

Surgical Ophthalmology and Diagnostics Tools:

The research trend discoveries maximize the opportunities to investigate the issues very minutely to decrease the risk of failure especially during surgical procedure like cataract and refractive surgery. The American Health Assistance Foundation, dedicated to eradicating age-related degenerative diseases, estimates that up to 11 million people in the United States have some form of AMD - a number expected to double by 2050. Estimates of the global cost of visual impairment AMD causes are $343 billion, including $255 billion in direct health care costs, according to the foundation. Ophthalmology represents 18 percent of the average case volume in surgery centers, second behind GI/endoscopy (25 percent). The average surgery center performs 4,869 cases annually, which would average to around 876 ophthalmology cases annually, according to VMG Health's 2009 Intellimarker.

Related Conferences:
8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference and Expo on Cataract and Refractive Surgery  August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016  Madrid, Spain;9th World Ophthalmic Conference Oct 27-28, 2016 Istanbul, Turkey;10th International Conference on Clinical & Experimental Ophthalmology Nov 28-30, 2016 Dubai, UAE;6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; Future World Ophthalmology Congress of the International Council of Ophthalmology 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal.

Ocular Immunology and Microbiology:

Many of the viruses, bacteria, parasites, and fungi that can invade the human body are also capable of attacking the surface or interior of the eye. The natural tendency for immunologic disease to affect the eye derives from a number of factors such as Antibody-dependent & antibody-mediated diseases, Uveitis, intraocular inflammation and cell-mediated diseases. The immune system plays a critical role during transplantation and as the corneal transplantation has become increasingly common since the 1960s and over 40,000 transplants were performed in 1990 in the United States and Canada. The 5-year failure rate for corneal grafts is approximately 35%; corneal graft rejection is the most common cause of graft failure in the late postoperative period but with the recent development in immunotherapy can be a breakthrough to overcome from all the limitations of the conventional procedures. The microbiological infection such as fungal endophthalmitis can affect the vitreous and anterior chamber of the eye and hence the uses of antibiotic in ocular infections have been increased to overcome these conditions. The consumables, equipment and technology markets in the microbiology industry totaled nearly $7.7 billion in 2012. This total is expected to grow from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound annual growth rate (CAGR) of 6.1% for the five-year period, 2013 to 2018.

Related Conferences:
2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference and Expo on Cataract and Refractive Surgery  August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016  Madrid, Spain;9th World Ophthalmic Conference Oct 27-28, 2016 Istanbul, Turkey;10th International Conference on Clinical & Experimental Ophthalmology Nov 28-30, 2016 Dubai, UAE;6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA;ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; Adaptive Optics and Wave front Control in Microscopy and Ophthalmology 5–7 October 2015 Paris, France; European Association for Vision andEye Research 2015 Nice 7–10 October 2015 Nice, France; Endocannabinoid Pharmacology Meeting – 2015 29–30 October 2015 Bern, Switzerland .

Vision Science

Vision science is a term used to encompass all studies of vision, such as how human and non-human organisms process visual information, how conscious visual perception works in humans, how to exploit visual perception for effective communication, and how artificial systems can do the same tasks.

Related Conferences:
International Conference and Expo on Cataract and Refractive Surgery  August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016  Madrid, Spain;9th World Ophthalmic Conference Oct 27-28, 2016 Istanbul, Turkey;10th International Conference on Clinical & Experimental Ophthalmology Nov 28-30, 2016 Dubai, UAE;6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA;XII International Congress of the Middle East Africa Council of Ophthalmology (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; Adaptive Optics and Wave front Control in Microscopy and Ophthalmology 5–7 October 2015 Paris, France; European Association for Vision and Eye Research 2015 Nice 7–10 October 2015 Nice, France; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States.

Ophthalmology Research and Novel Approaches

Novel approaches are referred to the techniques and procedure which is used to treat the ailment in specific manner to gain the maximum therapeutic effect. The novel approaches could be development in the ophthalmic formulation of drugs to reach out the desired site of action through different drug delivery systems and also usage of biomaterials, tissue science technologies, stem science technology to eradicate the various eye diseases.

Relevant Conferences:

6th Global Ophthalmologists Annual Meeting, May 16-18, 2016 Osaka, Japan, Global Pediatric OphthalmologyCongress, June 06-7, 2016 London, UK; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA;  International Conference and Expo on Cataract & Refractive Surgery  Aug 04-05, 2016 Manchester, UK; 9thGlobal Ophthalmology Summit, August 24-26, 2016 Sao Paulo, Brazil; 7th European Ophthalmology Conferences December 05-06, 2016  Madrid, Spain; 2nd International Conference on Eye and Vision  September 26-28, 2016  Orlando, Florida, USA; Global Ophthalmology & Glaucoma Conference, October 13-15, 2016 Kuala Lumpur, Malaysia;  International Conference & Expo on Optometry and Vision Science October 27-29, 2016 Rome, Italy; World Ophthalmology Conference, November 24-26, 2016 Melbourne, Australia; Association for Research in Vision and Ophthalmology 2016 (ARVO), May 1-5, 2016, Seattle, USA; IOA XIIIth InternationalOrthoptic Congress, June 27-30, 2016, Rotterdam, The Netherlands; European Association for Vision and Eye Research (EVER), October 5-8, 2016, Nice, France; American Academy of Ophthalmology Meeting, October 15-18, 2016, Chicago, USA; The 12th European Glaucoma Society Congress, June 19-22, 2016 Prague, Czech Republic; American Academy of Ophthalmology (AAO 2016- Innovate), October 15-18, 2016 Chicago, USA;American Glaucoma Society Annual Meeting, March 03-06, 2016 Fort Lauderdale, USA; Asia Pacific Glaucoma Society Congress, July 14-16, 2016 Chiang Mai, Thailand; for more meetings visit Ophthalmology Meetings,

Pediatric ophthalmology

Pediatric ophthalmology is a sub-speciality of ophthalmology concerned with eye diseases, visual development, and vision care in children. The pediatric ophthalmologist has additional training, experience, and expertise in examining children, and has the greatest knowledge of possible conditions that affect the pediatric patient and his/her eyes.  Neurologic development of vision occurs up until approximately age 12 years. Misalignment of the eyes (strabismus), uncorrected refractive error (myopia, hyperopia, and astigmatism), and asymmetry of refractive error between the two eyes can negatively affect this development.  If these conditions are diagnosed and treated early, good vision can develop and can be maintained.  Certain diseases elsewhere in the body, such as diabetes, can affect the eyes, and the pediatric ophthalmologist addresses these, as well.

Related Conferences:

6th Global Ophthalmologists Annual Meeting, May 16-18, 2016 Osaka, Japan, Global Pediatric OphthalmologyCongress, June 06-7, 2016 London, UK; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA;  International Conference and Expo on Cataract & Refractive Surgery  Aug 04-05, 2016 Manchester, UK; 9thGlobal Ophthalmology Summit, August 24-26, 2016 Sao Paulo, Brazil; 7th European Ophthalmology Conferences December 05-06, 2016  Madrid, Spain; 2nd International Conference on Eye and Vision  September 26-28, 2016  Orlando, Florida, USA; Global Ophthalmology & Glaucoma Conference, October 13-15, 2016 Kuala Lumpur, Malaysia;  International Conference & Expo on Optometry and Vision Science October 27-29, 2016 Rome, Italy; World Ophthalmology Conference, November 24-26, 2016 Melbourne, Australia ;Retina 2016, Hawaii, January 16-22, 2016, USA; 16th EURETINA Congress, September 08-11, 2016 Copenhagen, Denmark; American Society of Retina Specialists (ASRS) 34th Annual Meeting, August 10-14, 2016, California, USA; 19thRetina International World Congress, July 06-10, 2016, Taipei, Taiwan; 18th Annual: The Business of RetinaMeeting, April 09-10, 2016 Texas, USA; American Academy of Ophthalmology (AAO 2016- Innovate), October 15-18, 2016 Chicago, USA; American Glaucoma Society Annual Meeting, March 03-06, 2016 Fort Lauderdale, USA; Asia Pacific Glaucoma Society Congress, July 14-16, 2016 Chiang Mai, Thailand; for more meetings visitOphthalmology Meetings

 ConferenceseriesLLC is inviting you to attend The World Ophthalmic Oncology Congress is going to be held during September 26-27, 2016 at Orlando, Florida ,USA. Ophthalmic Oncology 2016 which is one of the American Ophthalmology Conference will bring together world-class professors, scientists and ophthalmologist to discuss strategies for Ophthalmology, it aims to bridge the gap between large and medium pharmaceutical, biotech and diagnostic companies, leading universities and clinical research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe. World Ophthalmic Oncology Congress 2016 maximizes the opportunity to interact with and learn from your peers from across the country and across the globe it held with the discussions on: Ophthalmic Oncology, Intraocular Cancer, Retinoblastoma, Ocular Melanoma, Lymphoma of the Eye, Eyelid Carcinoma, Childhood eye Cancer, Eye Cancer Symptoms, eye Cancer Diagnosis, Eye cancer Treatment, Ophthalmologists and case reports.  

Conference Series LLC, the host of this conference is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe.

Why to attend?

With members from around the world focused on learning about clinical ophthalmology, this is the single best opportunity of Ophthalmic Oncology Conferences to reach the largest assemblage of participants from the ophthalmology community. Conduct workshops, distribute information, meet with current and potential customers, make a splash with a new product line, and receive name recognition at this 3 days event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in field of ophthalmology are hallmarks of this conference.

Target Audience:

  • Ophthalmologists
  • Optometrist
  • Oncologists
  • Radiologists
  • Ophthalmology Researchers and Scholars
  • Ophthalmology Faculty
  • Medical Colleges
  • Ophthalmology Associations and Societies
  • Business Entrepreneurs
  • Vision Research Labs
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies

                                                                    

Ophthalmology Market Research in Melbourne, Australia:

Melbourne is the place where research of ophthalmology is finding a great scope. Many institution are forwarding their hand to improve the research. NHMRC which was established in 1936 and its broad strategic intent is better health for all Australians. It is governed by legislation and reports to the Minister for Health and Ageing. The NHMRC plays a pivotal role in providing independent advice on all aspects of health and health care delivery in Australia. This is achieved by managing the complementary functions of funding for health and medical research, providing ethical guidance on health and medical research issues, and providing health advice that is both current and relevant to the Australian community.


NHMRC’s research programs encompass the full spectrum of health and medical science, and funding is granted on the basis of scientific quality as judged by rigorous peer review.


While eye health research is not currently identified as an NHMRC research priority, nevertheless the NHMRC awarded 87 new and continuing grants totalling $9.6 million for vision-related research in 2004. Half of the grants (44) were for basic eye research, with an emphasis on neurology. A further third (30) were for clinical and medical science (including diagnosis and treatment) and the remaining 13 were for public health, with 7 grants for epidemiology and for preventative health.

The NHMRC has identified priority areas as outlined in the NHMRC’s Road Map. At the 144th (October 2002) meeting of the Council, the Council agreed to a number of recommendations, including to adopt Aboriginal and Torres Strait Islander Health research as a strategic priority, as well as to accept responsibility for implementing the Road Map and commit to allocating at least 5% of the total annual research funding to achieve this commitment over the course of the current triennium.

The Australian Government established the CRC Programme in 1990 to improve the effectiveness of Australia’s research and development effort. It links researchers with industry to focus Research & Development efforts on progress towards utilisation and commercialization. The Vision CRC was established in 2003. It is a synergistic collaboration of national and international researchers from 38 organisations involved in eye care and vision research, education and delivery. Vision CRC is a multi-node centre, with its hub at dedicated premises at the University of New South Wales in Kensington, Sydney.

 

Funds Alloted :

ORIA is one of the funding organisation which provides funds for research and also a self funded where itself does research.

The ORL researchers have been awarded consecutive grants from the Ophthalmic Research Institute of Australia from 2006-2011.

· ORIA 2006: Bioenergetic neuroprotection for retinal and optic nerve disease ($48000)

· ORIA 2007: The Spatiotemporal Pattern of Optic Nerve Pathology in Experimental Glaucoma ($50700)

· ORIA 2008: The role of Osteopontin in the Retina ($48250)

· ORIA 2009: The Effect of Hyperglycaemia on Experimental Glaucoma ($69030)

· ORIA 2010: Can topical glucose improve vision in glaucoma patients? ($33,000)

· ORIA 2011: Axonal Regeneration in experimental glaucoma ($49,725)

· ORIA 2012: Investigations into optic nerve injury in a rat model of glaucoma ($49,960)

 

Why Melbourne

Melbourne is a most populous city in the Australia. Melbourne rates highly in education, Melbourne is the place where research of ophthalmology is finding a great scope. Many institution are forwarding their hand to improve the research in ophthalmology.

Major Associations related to ophthalmology in Australia

· Australasian College for Emergency Medicine

· Australian Medical Association

· Australian and New Zealand College of Anaesthetists

· Doctors Reform Society of Australia

· National Prescribing Service

· Royal Australasian College of Physicians

· Royal Australasian College of Surgeons

· Royal Australian College of General Practitioners

· Royal Australian and New Zealand College of Ophthalmologists

 

Major Associations around the Globe related to Ophthalmology:

·  American  academy of Ophthalmology

· Afro-Asian Council of Ophthalmology

· All India Ophthalmological Society

· Asia Pacific Academy of Ophthalmology

· Canadian Ophthalmological Society

· Chinese Ophthalmological Society

· Canadian Ophthalmological Society

· Danish Ophthalmological Society

· European Society of Ophthalmology

· French Society of Ophthalmology

· German Ophthalmological Society

· Italian Society of Ophthalmology

· Japanese Ophthalmological Society

· Korean Ophthalmological Society

· Malaysian Society of Ophthalmology

· Ophthalmological Society of South Africa

· Ophthalmic Society Emirates Medical Association

· Royal College of Ophthalmologists, United Kingdom

· Saudi Ophthalmological Society

 

 

Statistical Analysis of Associations:

Figure1: Statistical Analysis of Eye Associations

Target Audience: Ophthalmologist, researchers, eye surgeons, physicians, eye care specialists,   professors, scientific community, delegates and students are the main participants for the conference.Business professionals (Directors, presidents, CEO) from eye equipment companies.

 

Graphical Representation of the Target Audience:

 

Eye Surgeons/Doctors: 50%

Researcher/ Professors: 30%

Business/ Marketing Eye Equipment’s: 20 %

Figure 2: Target Audience

 

 

Top universities in Melbourne:

·         University of Melbourne

·         Monash University

·         RMIT University

·         Swinburne University of Technology

·         La Trabe University

Figure3: Top universities in Melbourne:

Top Hospitals for Ophthalmology Treatment in Australia:

·         Calvary Hospital

·         Calvary John James Hospital

·         Royal North Shore Hospital

·         Queen Elizabeth II Jubilee Hospital

·         Townsville Hospital

·         Royal Victorian Eye & Ear Hospital

·         The Queen Elizabeth Hospital

 

Stasticial Representation of Top Hospitals for Ophthalmology Treatment:

Figure4: Hospitals for Ophthalmology Treatment

Eye 2015

The International Conference on Eye Disorder and Treatment (Eye-2015) hosted by OMICS Group took place at Double Tree by Hilton Baltimore- BWI Airport, USA during July 13-15, 2015. Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of OMICS Group Journals as well as from eminent scientists, talented researchers and young student community. The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates driving the three days event into the path of success with thought provoking keynote and plenary presentations highlighting the theme, “Scientific perspectives for a better vision and to pioneer innovations in ocular treatment & care”. Researchers and students who attended from different parts of the world has made the conference one of the most successful and productive events in 2015 from OMICS Group.

The conference was initiated with a warm welcome note from the Honorable guests and Keynote forum session which was sponsored by Visiometrics. The proceedings went through interactive sessions and panel discussions headed by Lyne Racette Indiana University, USA honorable Moderator for the conference.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

Age related cataract: Pathogenesis and possible therapy - Dr. Manuel B DatilesNational Institutes of Health, USA

Quality of vision, what do we need to know? - Dr. Jan BonelVisiometrics, Spain

The innovations and new technologies used in the diagnosis and treatment of glaucoma in Bolivia - Dr. Manuel Jose Justiniano, Bolivian Society of Glaucoma, Bolivia

Evidence-based decisions and real life applications - Dr. Albert S KhouriRutgers New Jersey Medical School, USA

Advances in retinoblastoma - Dr. Arpitha ParthasarathyUS Medical Innovations, USA

Eye-2015 Conference also witnessed symposium by Dr. Arpitha Parthasarathy, US Medical Innovations, USA along with Dr. Mary Beth Aronow, Johns Hopkins University, USA about “Selective ablation of ocular cancer cells and cancer stem cells with cold atmospheric plasma and advances in prognostication for uveal melanoma respectively”.

A workshop session on “Ophthalmic telemedicine and glaucoma management” chaired by Dr. Daniel Valverde, University of Guayaquil, Ecuador and presented by Dr. Albert S Khouri, Rutgers from New Jersey Medical School, USA enlightened the crowd with recent researches.

Also, the conference proceeding was encouraged through the wonderful special session by Dr. Cesar Gomezperalt, Vision Perception, Mexico about “Quality of vision and life perception after automated lamellar keratoplasty for treating moderate to severe keratoconus: Day one to full recovery”.

OMICS Group has taken the privilege of felicitating Eye-2015 Conference Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS Group, on behalf of the conference sponsor appreciates all the participants who put their efforts for this event and sincerely wishes them success in future endeavors.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Eye-2015 Conference. We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Group “Journal of Clinical and Experimental Ophthalmology” as a special issue.


Past Reports  Gallery  

Ophthalmology 2015

OMICS International played host to a diverse panel of key members of the Ophthalmology community from research lab, industry, academia and financial investment practices, discussing the future of Ophthalmology specialties. This event was really aimed for examining where the real ophthalmological specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Ophthalmology.

The conference had multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from various scientists, researchers, students and leaders from the field of Pharmacology who made this event successful.

Ophthalmology- 2015 Organizing Committee would like to thank the Moderators of the conference, Dr. Vijaya Juturu, Omni Active Health Technologies Inc., USA, Dr. Emmanuel S Buys, Massachusetts General Hospital, USA and Dr. Yoko Miura, University of Luebeck, Germany for their contributions which resulted in the smooth functioning of the conference.

The conference was initiated with a series of eponymous lectures delivered by both Honorable Guests and members of the Keynote forum. The list includes:

·         Maria Dolores Pinazo Duran from University of Valencia, Spain

·         Jacob Lorenzo-Morales University of La Laguna, Spain

·         Francisco Javier Carreras from University of Granada, Spain

·         Janardan Kumar from Becker College, USA

Instruction course carried by Dr. Atul Bansal, Consultant Ophthalmologist, University Hospital Coventry & Warwickshire, UK “Customising surgical glaucoma treatment to the patient and their disease”

OMICS 5th International Conference on Clinical & Experimental Ophthalmology was a great success with the support of international, multiprofessional steering committee and coordinated by the Journal of Clinical & Experimental Ophthalmology, International Journal of Ophthalmic Pathology and Biological Systems: Open Access.


Past Reports  Gallery  

Ophthalmology-2014

In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects of clinical skills, OMICS 4th International Conference on Clinical & Experimental Ophthalmology was held during July 14-16, 2014 in Baltimore, USA

OMICS Group played host to a diverse panel of key members of the Ophthalmology community from research lab, industry, academia and financial investment practices, discussing the future of Ophthalmology specialties. This event was really aimed for examining where the real ophthalmological specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Ophthalmology.

Focusing on Cornea and External Eye Disease, Retina and Retinal Disorders, Glaucoma: Visual Field Loss, Neuro-Ophthalmology, Ocular Microbiology and Immunology, Research Trends in Surgical and Medical Ophthalmology,Ophthalmic Research and Drug Development, and Novel Approaches to Ophthalmology Therapeutics as well, the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Ophthalmology-2014 Organizing Committee would like to thank the Moderator of the conference, Dr. Rebecca M. Sappington, Vanderbilt University School of Medicine, USA who contributed a lot for the smooth functioning of this event. We are also thank full to all the speakers who made this event a grand success, our special thanks to Dr. Chris Hekimian, Inventor of the Quantitative Retina Test Grid for exhibiting at the conference, many thanks to all the media partners for the promotion of our event.

The highlights of the meeting were the eponymous lectures, delivered by Chi-Chao Chan from National Institutes of Health, USAand Ashim K Mitra from University of Missouri-Kansas City, USA, Sayon Roy from Boston University School of Medicine, USA, Jayne S. Weiss fromLouisiana State University Health Sciences Center, USA. These talks were of great interest to the general ophthalmologists and were enormously informative.

OMICS 4th International Conference on Clinical & Experimental Ophthalmology was a great success with the support of international, multiprofessional steering committee and coordinated by the Journal of Clinical & Experimental Ophthalmology, International Journal of Ophthalmic Pathology and Biological Systems: Open Access.


Past Reports  Gallery  

Ophthalmology-2013

The 3rd International Conference on Clinical & Experimental Ophthalmology, hosted by the OMICS Group was successfully held during April 15-17, 2013 in Chicago/Northbrook, USA. Outstanding response and active participation received from the Researchers, Leaders from Pharmaceutical R&D sectors, Government Organizations, and Principal Investigators. And Editorial Board Members of OMICS Group helped in making this meeting an ostentatious success.

Keynote Speakers:

•             Dr. Chi-Chao Chan, National Institutes of Health, USA

•             Dr. Lea Hyvarinen, Technical University of Dortmund, Germany

•             Dr. Christopher Hekimian, dxdt Engineering and Research, USA

•             Dr. Sayon Roy, University of Naples, Italy

A series of invited lectures by Honorable guests and members of the Keynote forum marked the commencement of the event. Keynote session was very prolific to the scientific community and they lifted up solutions and illustrated a way on the theme "Intolerable Disparity in Vision and Novel Therapies"

Scientific sessions established active contribution from researchers and principal investigators, and the Poster presentations were phenomenally excellent with the enthusiastic students and fellow researchers. It established a new prospect and hopes on ongoing projects in field of Ophthalmology.

OMICS Group felicitated all the Organizing Committee Members and Editorial Board Members who enthusiastically participated in the conference and made this meeting a huge success.

OMICS Group on behalf of OCMs and EBMs congratulates all the Best Poster Awardees for their outstanding contribution in the field of Ophthalmology and simultaneously encourage all the participants who tried to put their efforts in poster presentations and wish them success for their future research.


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 24-25, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations